Correlate ECOG performance status with chemotherapy toxicity risk, dose intensity maintenance, and survival benefit to guide treatment decision-making in borderline PS 2–3 oncology patients.
Enter the values for the scenario you are assessing. Correlate ECOG performance status with chemotherapy toxicity risk, dose intensity maintenance, and survival benefit to guide treatment decision-making in borderline PS 2–3 oncology patients. Use the ps chemo tolerance result to inform your calculation.